BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S revenue for the last year amounted to 285.23 M GBP, the most of which — 318.07 M GBP — came from its highest performing source at the moment, Pharmaceutical Formulations and Active Pharmaceutical Ingredients, the year earlier bringing 316.67 M GBP. The greatest contribution to the revenue figure was made by Bangladesh — last year it brought BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S 318.07 M GBP, and the year before that — 316.67 M GBP.